C74.90

Billable

Malignant neoplasm of unsp part of unspecified adrenal gland

Malignant neoplasm of unspecified part of unspecified adrenal gland

Status

Billable / Specific

Block

C73-C75

Parent Code

C74.9
Related Codes(2)
C74.91

Malignant neoplasm of unsp part of right adrenal gland

BillableC74.92

Malignant neoplasm of unspecified part of left adrenal gland

Billable
Also Known As / Clinical Terms(139)

SNOMED CT

UMLS

Clinical Terms

  • International neuroblastoma staging system stage 4S
  • Metastasis to adrenal gland
  • Metastatic neuroblastoma to paraspinal area
  • Secondary neuroblastoma of thorax
  • Metastatic neuroblastoma of pelvis
  • Secondary neuroblastoma of pelvis
  • Metastatic neuroblastoma to pelvis
  • Secondary malignant neoplasm of adrenal gland
  • Pelvic neuroblastoma
  • Secondary neuroblastoma of paraspinal area
  • International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with ganglioneuroblastoma, nodular (composite Schwannian stroma-rich/stroma-dominant and stroma-poor)
  • International neuroblastoma pathology classification finding
  • International neuroblastoma staging system stage 1
  • International neuroblastoma staging system stage 2A
  • Metastatic neuroblastoma of abdominothoracic structure
  • INSS stage finding -International neuroblastoma staging system stage finding
  • International neuroblastoma staging system stage 2B
  • International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroma (Schwannian stroma-dominant) maturing, or mature
  • International neuroblastoma pathology classification: Unfavourable histology group, patient of any age, with undifferentiated neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index
  • Secondary neuroblastoma of central nervous system
  • Metastatic neuroblastoma to abdominothoracic structure
  • Metastatic neuroblastoma of central nervous system
  • Metastatic neuroblastoma of adrenal gland
  • Metastatic neuroblastoma
  • International neuroblastoma staging system stage 3
  • Secondary neuroblastoma of abdominothoracic structure
  • Metastatic neuroblastoma of thorax
  • International neuroblastoma pathology classification: Unfavourable histology group, patient of any age, with ganglioneuroblastoma, nodular (composite Schwannian stroma-rich/stroma-dominant and stroma-poor)
  • Metastatic malignant neoplasm of adrenal gland
  • Metastatic malignant neoplasm to adrenal gland
  • International neuroblastoma pathology classification: Unfavorable histology group, patient of any age, with undifferentiated neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index
  • Primary neuroblastoma
  • International neuroblastoma pathology classification: Favorable histology group, patient age 1.5 years up to but less than 5 years, with differentiating neuroblastoma (Schwannian stroma-poor), and low mitosis-karyorrhexis index
  • Neuroblastoma of central nervous system
  • Secondary neuroblastoma of brain
  • Thoracic neuroblastoma
  • Malignant tumour of adrenal gland
  • Metastatic neuroblastoma to central nervous system
  • Adrenal neuroblastoma
  • Cancer of adrenal gland
  • International neuroblastoma staging system stage finding
  • Neuroblastoma
  • Neuroblastoma of brain
  • Primary hyperaldosteronism due to aldosterone-secreting malignant neoplasm of adrenal gland
  • Adrenal gland malignancy
  • International neuroblastoma pathology classification: Unfavourable histology group, patient 5 years or older, with any subtype of neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index
  • Hyperaldosteronism due to carcinoma
  • Suprarenal metastasis
  • International neuroblastoma pathology classification: Favorable histology group, patient of any age with ganglioneuroblastoma, intermixed (Schwannian stroma-rich)
  • Metastatic neuroblastoma to adrenal gland
  • International neuroblastoma pathology classification: Unfavourable histology group, patient less than 1.5 years old, with poorly differentiated or differentiating neuroblastoma (Schwannian stroma-poor) and high mitosis-karyorrhexis index
  • Metastatic neuroblastoma of brain
  • Metastatic neuroblastoma to brain
  • Secondary neuroblastoma of adrenal gland
  • International neuroblastoma staging system stage 4
  • Malignant tumor of adrenal gland
  • International neuroblastoma pathology classification: Unfavorable histology group, patient 1.5 yr up to but less than 5 yr, with poorly differentiated neuroblastoma and any MKI or differentiating neuroblastoma and intermediate or high MKI
  • International neuroblastoma pathology classification: Unfavorable histology group, patient 5 years or older, with any subtype of neuroblastoma (Schwannian stroma-poor) and any mitosis-karyorrhexis index
  • Abdominothoracic neuroblastoma
  • Metastatic neuroblastoma to thorax
  • Primary malignant neoplasm of adrenal gland
  • Primary adrenal neuroblastoma
  • Aldosterone-producing carcinoma
  • Cancer metastatic to adrenal gland
  • International neuroblastoma pathology classification: Unfavorable histology group, patient less than 1.5 years old, with poorly differentiated or differentiating neuroblastoma (Schwannian stroma-poor) and high mitosis-karyorrhexis index
  • International neuroblastoma pathology classification: Favorable histology group, patient less than 1.5 years of age, with poorly differentiated neuroblastoma (Schwannian stroma-poor), and low or intermediate mitosis-karyorrhexis index
  • International neuroblastoma pathology classification: Unfavourable histology group, patient 1.5 yr up to but less than 5 yr, with poorly differentiated neuroblastoma and any MKI or differentiating neuroblastoma and intermediate or high MKI
  • Metastatic neuroblastoma of paraspinal area
Frequently Asked Questions
What is the ICD-10 code for malignant neoplasm of unsp part of unspecified adrenal gland?

The ICD-10-CM code for malignant neoplasm of unsp part of unspecified adrenal gland is C74.90. The full clinical description is "Malignant neoplasm of unspecified part of unspecified adrenal gland". C74.90 is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code C74.90 mean?

ICD-10-CM code C74.90 represents “Malignant neoplasm of unspecified part of unspecified adrenal gland”. It is classified under Chapter 2: Neoplasms and is a billable/specific code that can be used on a claim.

Is C74.90 a billable code?

Yes, C74.90 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is C74.90 in?

C74.90 is in Chapter 2: Neoplasms (codes C00-D49).

What SNOMED CT codes does C74.90 map to?

C74.90 maps to 38 SNOMED CT concepts: 281566005, 363355002, 281562007, 703306007, 94161006, and 33 more. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for C74.90?

C74.90 is linked to 1 UMLS Concept Unique Identifier: C2845946. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

How does C74.90 relate to ICF functioning codes?

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like malignant neoplasm of unsp part of unspecified adrenal gland affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

What is the ICD-11 equivalent of C74.90?

There is no direct ICD-11 mapping available for C74.90 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Try FreeView API Docs

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.